too early for licensing deal (imo)
good to pay attention to what else is going on coz ATX doesn’t operate in a vacuum. Several FAK inhibitors in development, the one from Verastem oncology looks the most advanced. They also tout theirs as “best in class”!!
- Forums
- ASX - By Stock
- ATX
- Ann: Update on ACCENT Trial in Pancreatic Cancer
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-21
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $37.01M |
Open | High | Low | Value | Volume |
14.0¢ | 14.0¢ | 13.5¢ | $29.17K | 210.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 63244 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 65766 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 63244 | 0.135 |
11 | 311786 | 0.130 |
4 | 237518 | 0.125 |
2 | 70125 | 0.120 |
2 | 266206 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 65766 | 3 |
0.145 | 149180 | 3 |
0.150 | 580174 | 9 |
0.155 | 539483 | 3 |
0.160 | 311320 | 4 |
Last trade - 13.04pm 19/08/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |